title: Early regional assessment of LV mass regression and function after stentless valve replacement: comparative randomized study.
abstract: Early regional performance and hypertrophy regression after stentless aortic valve replacement are still incompletely characterized. We compared early postoperative changes of segmental thickness and function after stentless and stented aortic valve replacement as assessed by cardiac magnetic resonance (CMR). In 16 patients randomly assigned to stented (Mosaic, 8 patients) and stentless (Freestyle, 8 patients) groups, 4 parallel short-axis images at the level of the apex (slice 4), midventricle (slices 2-3), and mitral valve (slice 1) were obtained with a 1.5 T CMR scanner (Magnetom Sonata, Siemens) before and 1 month after surgery. Cine images were obtained using an echo gradient sequence. Left ventricle mass was calculated as the difference between the left ventricular end-diastolic volume at the epicardial and endocardial borders multiplied by a myocardium density factor (1.05). Each slice was divided into 8 segments (octants) from anterior (octant I-II) to septal (octant V-VIII). A total of 32 segments encompassed the entire heart. From each of these elements end diastolic thickness and systolic function (fractional thickening) were calculated. In stentless valves significant reduction of septal octant thickness on the midventricular slice was noted. There was no difference in regional systolic function-segment thickening. In stented valves no segmental thickness changes were observed. In stentless valves there was early postoperative thickness reduction of septal segments at the midventricular level. However, this finding did not coincide with changes in segmental function.
authors.affiliation: 2nd Department of Cardiac Surgery, Medical University of Silesia, Katowice, Poland. marekjas@hotmail.com
authors.forename: M J
authors.initials: MJ
authors.lastname: Jasinski
authors.forename: P
authors.initials: P
authors.lastname: Ulbrych
authors.forename: M
authors.initials: M
authors.lastname: Kolowca
authors.forename: A
authors.initials: A
authors.lastname: Szafranek
authors.forename: J
authors.initials: J
authors.lastname: Baron
authors.forename: S
authors.initials: S
authors.lastname: Wos
mesh_terms: D000368:Aged; D005260:Female; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000175:diagnosis* / Q000209:etiology*; D008297:Male; D015607:Stents; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000175:diagnosis* / Q000209:etiology*